Strategies To Create Integrated Global Cold Chain Supply Networks To Be Presented By Catalent Expert At Clinical Trial Supply Conference

Somerset, N.J., – March 7, 2016 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, today announced that Eric Valentine, Global Director, Clinical Distribution Services, will present at the upcoming Clinical Trial Supply New England Conference, to be held at the Revere Hotel, Boston, MA, on March 9th – 10th 2016.

Mr. Valentine’s presentation, on Wednesday March 9th, at 10.00 a.m., is entitled “Partnering to Develop an Integrated Cold Chain Supply Network,” and will discuss how the growing demand for global cold chain supply capabilities requires successful partnerships between multiple organizations. He will highlight key considerations when looking to develop integrated supply chain solutions in support of clinical trials, including the identification of strategic geographic areas for supply chain investment. In addition, Mr. Valentine will discuss how technology and the increasing complexity of clinical trials are leading to a new demand-led clinical supply chain model.

Mr. Valentine is the Global Director of Distribution Services for Catalent Pharma Solutions, responsible for developing the facility network and logistics strategies in support of Catalent's Clinical Supply Services business. He has a background that includes 20 years' experience serving in leadership positions in the CRO and drug development services industries. Mr. Valentine holds an MBA in Finance from Seton Hall University, New Jersey, and a B.A. in Business Administration from the University of Vermont.

For more information on the Clinical Trial Supply New England Conference, visit: and to arrange a meeting with Mr. Valentine at the event, contact Richard Kerns at NEPR -

About Catalent

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit 

More products. Better treatments. Reliably supplied.™


    T (03) 3470-2311
    F (03) 3408-5554

    T(0537) 29-1131